相关实验视频

Updated: Jul 26, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

SARS-CoV-2 中和抗体疗法:最近的进展和未来的挑战

Mingtao Liu¹, Zhiman Liang¹, Zhangkai J Cheng¹

¹Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Reviews in medical virology

|June 16, 2023

概括

中和抗体为COVID-19提供了一个有前途的新治疗策略,针对SARS-CoV-2变种. 研究探讨了针对各种病毒区域的抗体,并通过体外测试评估了它们的有效性.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
传染性疾病传染性疾病

背景情况:

随着COVID-19的流行,全球健康面临着重大挑战,有效的治疗方法有限.
基于中和抗体的疗法正在成为预防和管理COVID-19等传染病的有希望的方法.

研究的目的:

综合当前关于COVID-19中和抗体的知识,针对不同的区域 (RBD,非RBD,宿主细胞,交叉中和).
批判性地审查关于针对COVID-19的基于抗体的干预的科学文献.
检查抗体功能评估,专注于体外测试,并确定未来的研究方向.

主要方法:

关于COVID-19中和抗体的科学出版物的文献综述.
对研究针对针对不同SARS-CoV-2区域的抗体的研究进行分析.
用于功能性评估抗体疗效的体外测试的评估.

主要成果:

全球范围内正在进行众多COVID-19中和抗体研究,其中一些正在进入临床阶段.
针对SARS-CoV-2不同区域的抗体,包括受体结合域 (RBD),显示出治疗潜力.
在体外测试对于评估这些中和抗体的功能能力至关重要.

结论:

COVID-19 中和抗体代表了针对SARS-CoV-2及其变体的创新治疗策略.
需要进一步的研究来应对挑战,并优化基于抗体的疗法的开发.
了解抗体点和功能评估是推进治疗选择的关键.

关键词:

在 COVID-19 疫情中,这就是SARS-CoV-2病毒.中和抗体的抗体.

更多相关视频

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Published on: August 12, 2021

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...